Page last updated: 2024-08-25

rosiglitazone and Adrenal Cancer

rosiglitazone has been researched along with Adrenal Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chang, MS; Choi, OK; Kim, SW; Kim, SY; Park, KS; Shin, CS	1

Other Studies

1 other study(ies) available for rosiglitazone and Adrenal Cancer

Article	Year
Thiazolidinediones inhibit the growth of PC12 cells both in vitro and in vivo. Biochemical and biophysical research communications, 2008, Jun-27, Volume: 371, Issue:2 Topics: Adrenal Gland Neoplasms; Animals; Antineoplastic Agents; Caspase 3; Cell Proliferation; Cyclin E; Cyclin-Dependent Kinase 2; Humans; Ki-67 Antigen; Mice; Nerve Growth Factor; Neurons; PC12 Cells; Pheochromocytoma; Pioglitazone; PPAR gamma; Rats; Rosiglitazone; Thiazolidinediones	2008

Article

Year

Thiazolidinediones inhibit the growth of PC12 cells both in vitro and in vivo.

Biochemical and biophysical research communications, 2008, Jun-27, Volume: 371, Issue:2

Topics: Adrenal Gland Neoplasms; Animals; Antineoplastic Agents; Caspase 3; Cell Proliferation; Cyclin E; Cyclin-Dependent Kinase 2; Humans; Ki-67 Antigen; Mice; Nerve Growth Factor; Neurons; PC12 Cells; Pheochromocytoma; Pioglitazone; PPAR gamma; Rats; Rosiglitazone; Thiazolidinediones

2008